Doctor Raphael Wurm
Medical University of Vienna, Vienna (Austria)
RAS Antagonists and beta blockers stabilize HbA1c and improve insulin resistance in patients with diabetes free from cardiac disease
Event: Heart Failure 2018
Topic: Diabetes and the Heart
Session: Diabetes and the Heart
Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles
Event: ESC Congress 2016
Topic: Cardiotoxicity of drugs
Session: Cancer and cardiotoxicity: from bench to bedside
Fingerprint of the renin-angiotensin-system during ARNI therapy in patients with systolic heart failure
Event: ESC Congress 2016
Topic: Pharmacologic therapy
Session: Drug therapy of heart failure
ESC 365 is supported by
